Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
BMC Anesthesiol ; 22(1): 209, 2022 07 07.
Article in English | MEDLINE | ID: mdl-35794523

ABSTRACT

BACKGROUND: The coronavirus-2019 (COVID-19) pandemic highlighted the unfortunate reality that many hospitals have insufficient intensive care unit (ICU) capacity to meet massive, unanticipated increases in demand. To drastically increase ICU capacity, NewYork-Presbyterian/Weill Cornell Medical Center modified its existing operating rooms and post-anaesthesia care units during the initial expansion phase to accommodate the surge of critically ill patients. METHODS: This retrospective chart review examined patient care in non-standard Expansion ICUs as compared to standard ICUs. We compared clinical data between the two settings to determine whether the expeditious development and deployment of critical care resources during an evolving medical crisis could provide appropriate care. RESULTS: Sixty-six patients were admitted to Expansion ICUs from March 1st to April 30th, 2020 and 343 were admitted to standard ICUs. Most patients were male (70%), White (30%), 45-64 years old (35%), non-smokers (73%), had hypertension (58%), and were hospitalized for a median of 40 days. For patients that died, there was no difference in treatment management, but the Expansion cohort had a higher median ICU length of stay (q = 0.037) and ventilatory length (q = 0.015). The cohorts had similar rates of discharge to home, but the Expansion ICU cohort had higher rates of discharge to a rehabilitation facility and overall lower mortality. CONCLUSIONS: We found no significantly worse outcomes for the Expansion ICU cohort compared to the standard ICU cohort at our institution during the COVID-19 pandemic, which demonstrates the feasibility of providing safe and effective care for patients in an Expansion ICU.


Subject(s)
COVID-19 , Pandemics , Critical Care , Female , Humans , Intensive Care Units , Male , Middle Aged , Retrospective Studies
2.
Clin J Am Soc Nephrol ; 17(6): 890-901, 2022 06.
Article in English | MEDLINE | ID: mdl-35595531

ABSTRACT

Mechanical life support therapies exist in many forms to temporarily replace the function of vital organs. Generally speaking, these tools are supportive therapy to allow for organ recovery but, at times, require transition to long-term mechanical support. This review will examine nonrenal extracorporeal life support for cardiac and pulmonary support as well as other mechanical circulatory support options. This is intended as a general primer and overview to assist nephrologist consultants participating in the care of these critically ill patients who often experience acute renal injury as a result of cardiopulmonary shock and from their exposure to mechanical circulatory support.


Subject(s)
Acute Kidney Injury , Extracorporeal Membrane Oxygenation , Heart Failure , Heart-Assist Devices , Acute Kidney Injury/therapy , Consultants , Critical Illness , Extracorporeal Membrane Oxygenation/adverse effects , Heart Failure/therapy , Humans
3.
Semin Thorac Cardiovasc Surg ; 34(1): 182-188, 2022.
Article in English | MEDLINE | ID: mdl-33444770

ABSTRACT

As New York State quickly became the epicenter of the COVID-19 pandemic, innovative strategies to provide care for the COVID-19 negative patients with urgent or immediately life threatening cardiovascular conditions became imperative. To date, there has not been a focused analysis of patients undergoing cardiothoracic surgery in the United States during the COVID-19 pandemic. Therefore, we seek to summarize the selection, screening, exposure/conversion, and recovery of patients undergoing cardiac surgery during the peak of the COVID-19 pandemic. We retrospectively reviewed a prospectively maintained institutional database for patients undergoing urgent or emergency cardiac surgery from March 16, 2020 to May 15, 2020, encompassing the peak of the COVID-19 pandemic. All patients were operated on in a single institution in New York City. Preoperative demographics, imaging studies, intraoperative findings, and postoperative outcomes were reviewed. Between March 16, 2020 and May 15, 2020, a total of 54 adult patients underwent cardiac surgery. Five patients required reoperative sternotomy and cardiopulmonary bypass was utilized in 81% of cases. Median age was 64.3 (56.0; 75.3) years. Two patients converted to COVID-19 positive during the admission. There was one operative mortality (1.9%) associated with an acute perioperative COVID-19 infection. Median length of hospital stay was 5 days (4.0; 8.0) and 46 patients were discharged to home. There was 100% postoperative follow up and no patient had COVID-19 conversion following discharge. The delivery of cardiac surgical care was safely maintained in the midst of a global pandemic. The outcomes demonstrated herein suggest that with proper infection control, isolation, and patient selection, results similar to those observed in non-COVID series can be replicated.


Subject(s)
COVID-19 , Cardiac Surgical Procedures , Adult , Cardiac Surgical Procedures/adverse effects , Cardiac Surgical Procedures/methods , Humans , Middle Aged , Pandemics , Retrospective Studies , SARS-CoV-2 , Treatment Outcome , United States
4.
J Cardiothorac Vasc Anesth ; 36(7): 1859-1866, 2022 07.
Article in English | MEDLINE | ID: mdl-34903458

ABSTRACT

OBJECTIVE: In this study of women in cardiothoracic anesthesiology, the authors aimed to characterize demographics, roles in leadership, and perceived professional challenges. DESIGN: A prospective cross-sectional survey of female cardiothoracic anesthesiologists in the United States. SETTING: An internet-based survey of 43 questions was sent to women in cardiothoracic anesthesiology. The survey included questions on demographics, leadership, and perceptions of professional challenges including career advancement, compensation, promotion, harassment, and intimidation. PARTICIPANTS: A database of women in cardiothoracic anesthesiology was created via personal contacts and snowball sampling. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: A total of 153 responses were analyzed, for a response rate of 65.1%. Most respondents were at the Clinical Instructor or Assistant Professor rank. Many women perceived that compensation, promotion, authorship, and career advancement were affected by gender. Furthermore, 67% of respondents identified having children as having a negative impact on career advancement. Many women reported experiencing derogatory comments (55.6%), intimidation (57.8%), microaggression (69.6%), sexual harassment (25.2%), verbal harassment (45.2%), and unwanted physical or sexual advances (24.4%). These behaviors were most often from a surgical attending, anesthesia attending, or patient. CONCLUSION: This survey study of women in cardiothoracic anesthesiology found that many women perceived inequities in financial compensation, authorship opportunities, and promotion; in addition, many felt that their career advancement was impacted negatively by having children. A striking finding was that the majority of women have experienced intimidation, derogatory comments, and microaggressions in the workplace.


Subject(s)
Anesthesiology , Sexual Harassment , Authorship , Child , Cross-Sectional Studies , Female , Humans , Prospective Studies , Surveys and Questionnaires , United States
5.
J Card Surg ; 36(5): 1668-1671, 2021 May.
Article in English | MEDLINE | ID: mdl-32939825

ABSTRACT

BACKGROUND AND AIM: First reported in December of 2019, the COVID-19 pandemic caused by SARS-CoV-2 has had a profound impact on the implementation of care. Here, we describe our institutional experience with a rapid influx of patients at the epicenter of the pandemic. METHODS: We retrospectively review our experience with the departments of cardiology, cardiothoracic surgery, anesthesia, and critical care medicine and summarize protocols developed in the midst of the pandemic. RESULTS: The rapid influx of patients requiring an intensive level of care required a complete restructuring of units, including the establishment of a new COVID-19 negative unit for the care of patients requiring urgent or emergent non-COVID-19 related care including open-heart surgery. This unique unit allowed for the delivery of safe and effective care in the epicenter of the pandemic. CONCLUSIONS: Here, we demonstrate the response of a large tertiary academic medical center to the COVID-19 pandemic. Specifically, we demonstrate how rapid structural changes can allow for the continued delivery of cardiac surgical care with similar outcomes as those reported before the pandemic.


Subject(s)
COVID-19 , Cardiac Surgical Procedures , Humans , New York , Pandemics , Retrospective Studies , SARS-CoV-2
7.
J Cardiothorac Vasc Anesth ; 34(12): 3259-3266, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32507458

ABSTRACT

OBJECTIVE: To examine sex differences in inpatient mortality and 30-day and 90-day readmissions after coronary artery bypass grafting (CABG) among a multistate population. DESIGN: A retrospective analysis of patient hospitalization and discharge records. SETTING: All-payer patients in nonpsychiatric hospitals in New York, Maryland, Florida, Kentucky, and California. PARTICIPANTS: A total of 304,080 patients from the State Inpatient Databases Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality from January 2007 to December 2014 who underwent CABG surgery. INTERVENTIONS: Bivariate analysis and multivariate logistic regression were performed to obtain unadjusted rates and adjusted odds ratios, respectively, for in-hospital mortality and readmissions by sex. MEASUREMENTS AND MAIN RESULTS: Of the patients who underwent CABG, 5,699 patients (1.87%) died, including 2,131 women (2.65%) and 3,568 men (1.60%). The authors found that women were 32% more likely to die compared with men (adjusted odds ratio [aOR]: 1.32, 95% confidence interval [CI]: 1.25-1.40) after adjusting for age, race, insurance status, median income, Elixhauser comorbidity index measures, year of procedure, state, and hospital surgical volume. Women, compared with men, also had significantly increased adjusted odds of 30-day and 90-day readmissions (30-day aOR: 1.24, 95% CI: 1.21-1.28; 90-day aOR: 1.25, 95% CI: 1.22-1.28). CONCLUSION: This study demonstrated that female patients who undergo CABG are at a greater risk of in-hospital death and 30-day and 90-day readmission compared with men. This sex-based disparity in outcomes has persisted since identification some 40 years ago.


Subject(s)
Patient Readmission , Sex Characteristics , Coronary Artery Bypass , Female , Hospital Mortality , Humans , Male , Postoperative Complications/epidemiology , Retrospective Studies , Risk Factors
9.
Am J Respir Crit Care Med ; 201(11): 1337-1344, 2020 06 01.
Article in English | MEDLINE | ID: mdl-32298146

ABSTRACT

In response to the estimated potential impact of coronavirus disease (COVID-19) on New York City hospitals, our institution prepared for an influx of critically ill patients. Multiple areas of surge planning progressed, simultaneously focused on infection control, clinical operational challenges, ICU surge capacity, staffing, ethics, and maintenance of staff wellness. The protocols developed focused on clinical decisions regarding intubation, the use of high-flow oxygen, engagement with infectious disease consultants, and cardiac arrest. Mechanisms to increase bed capacity and increase efficiency in ICUs by outsourcing procedures were implemented. Novel uses of technology to minimize staff exposure to COVID-19 as well as to facilitate family engagement and end-of-life discussions were encouraged. Education and communication remained key in our attempts to standardize care, stay apprised on emerging data, and review seminal literature on respiratory failure. Challenges were encountered and overcome through interdisciplinary collaboration and iterative surge planning as ICU admissions rose. Support was provided for both clinical and nonclinical staff affected by the profound impact COVID-19 had on our city. We describe in granular detail the procedures and processes that were developed during a 1-month period while surge planning was ongoing and the need for ICU capacity rose exponentially. The approaches described here provide a potential roadmap for centers that must rapidly adapt to the tremendous challenge posed by this and potential future pandemics.


Subject(s)
Coronavirus Infections/epidemiology , Health Resources/supply & distribution , Hospitals , Pneumonia, Viral/epidemiology , Surge Capacity , Airway Management , Betacoronavirus , COVID-19 , Critical Illness , Hospitalization , Humans , Infection Control/organization & administration , Intensive Care Units , New York City/epidemiology , Pandemics , SARS-CoV-2 , Workforce/organization & administration
10.
Semin Cardiothorac Vasc Anesth ; 24(2): 149-158, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32340560

ABSTRACT

This annual article summarizes key findings from notable studies published in 2019 relevant to the practice of cardiothoracic critical care medicine. This year's article encompasses updates to the literature on enhanced recovery after cardiac surgery, extracorporeal membranous oxygenation, delirium, and primary graft dysfunction after heart transplant.


Subject(s)
Cardiac Surgical Procedures , Critical Care , Acetaminophen/therapeutic use , Cardiac Surgical Procedures/adverse effects , Cardiac Surgical Procedures/methods , Delirium/prevention & control , Enhanced Recovery After Surgery , Extracorporeal Membrane Oxygenation , Heart Transplantation/adverse effects , Humans
11.
J Cardiothorac Vasc Anesth ; 34(10): 2776-2792, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32139341

ABSTRACT

Venoarterial extracorporeal membrane oxygenation (ECMO) is a well-established technique to rescue patients experiencing cardiogenic shock. As a form of temporary mechanical circulatory support, venoarterial ECMO can be life-saving, but it is resource intensive and associated with substantial morbidity and mortality. Optimal clinical outcomes require specific expertise in the principles and nuances of ECMO physiology and management. Key considerations discussed in this review include hemodynamic assessment and goals; pharmacologic anticoagulation; ECMO weaning strategies; and the prevention, evaluation, and treatment of common complications.


Subject(s)
Extracorporeal Membrane Oxygenation , Hemodynamics , Humans , Shock, Cardiogenic/therapy
12.
J Cardiothorac Vasc Anesth ; 34(1): 267-277, 2020 Jan.
Article in English | MEDLINE | ID: mdl-30930139

ABSTRACT

The application and evolution of total endoscopic robotic cardiac surgery (TERCS) has become greater as institutions and surgeons become more comfortable with robotic technology. Over the years many improvements have been made to facilitate technically challenging cardiac procedures using robotics and increase overall survival and quality of life for these patients. However, a dedicated multidisciplinary approach led by a core group of clinicians is necessary for good patient experience and outcomes. In addition, good communication and performance improvement measures with attention to detailed perioperative management are essential to a successful robotic cardiac program.


Subject(s)
Anesthetics , Cardiac Surgical Procedures , Robotics , Humans , Minimally Invasive Surgical Procedures , Quality of Life
13.
J Card Surg ; 34(8): 684-689, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31212394

ABSTRACT

BACKGROUND: The primary objective of this study was to identify the specific predictors of early and late stroke in patients after open heart surgery. Secondary outcomes included (a) risk factors for perioperative stroke, (b) anatomic location of stroke according to time of presentation, and (c) the impact of stroke on operative mortality. METHODS: Adult patients undergoing open cardiac surgery with cardiopulmonary bypass from 2006 to 2016 at the New York Presbyterian Hospital/Weill Cornell Medicine were retrospectively reviewed. In total 7957 patients were included. We compared the demographic and perioperative variables in three groups: no stroke, early stroke, and late stroke using regression analysis. RESULTS: The incidence of perioperative stroke for the entire study period was 1.5% (117 of 7957). Early stroke occurred in 84 (71.8%) patients, whereas late stroke occurred in 33 (28.2%). Early strokes were usually embolic events (64 of 66, 97.0%, P = .66) on the right side (30 of 66, 45.5%, P < .001), in the anterior circulation (38 of 66, 57.6%, P = .001), or in multiple distributions (28 of 66, 42.4%, P = .002). Late strokes were more likely left-sided (16 of 28, 57.1%, P < .001) and uncommonly in both the anterior and posterior hemispheres (1 of 28, 3.6%, P = .001). Stroke, regardless of timing, was a significant predictor of operative mortality (odds ratio, 11.0, confidence interval, 6.1-19.7, P < .001). CONCLUSIONS: Early and late strokes after cardiac surgery have distinct incidence, location, and likely etiology. Both early and late strokes portend a very high incidence of operative mortality.


Subject(s)
Cardiac Surgical Procedures , Postoperative Complications/etiology , Stroke/etiology , Aged , Aged, 80 and over , Cardiac Surgical Procedures/mortality , Cardiopulmonary Bypass , Female , Forecasting , Humans , Incidence , Male , Middle Aged , Postoperative Complications/epidemiology , Regression Analysis , Retrospective Studies , Risk Factors , Stroke/epidemiology , Time Factors
14.
AMA J Ethics ; 21(5): E401-406, 2019 05 01.
Article in English | MEDLINE | ID: mdl-31127919

ABSTRACT

Decision making on behalf of an incapacitated patient is challenging, particularly in the context of venoarterial extracorporeal membrane oxygenation (VA-ECMO), a medically complex, high-risk, and costly intervention that provides cardiopulmonary support. In the absence of a surrogate and an advance directive, the clinical team must make decisions for such patients. Because states vary in terms of which decisions clinicians can make, particularly at the end of life, the legal landscape is complicated. This commentary on a case of withdrawal of VA-ECMO in an unrepresented patient discusses Extracorporeal Life Support Organization guidelines for decision making, emphasizing the importance of proportionality in a benefits-to-burdens analysis.


Subject(s)
Decision Making/ethics , Emergency Service, Hospital/ethics , Extracorporeal Membrane Oxygenation/ethics , Third-Party Consent/ethics , Third-Party Consent/legislation & jurisprudence , Withholding Treatment/ethics , Adult , Extracorporeal Membrane Oxygenation/methods , Humans , Male , Practice Guidelines as Topic , Risk Assessment , Tachycardia, Ventricular/diagnosis , Terminally Ill
15.
Semin Cardiothorac Vasc Anesth ; 23(2): 156-163, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30985250

ABSTRACT

In this article, we present the annual review of the literature relevant for the practice of cardiovascular critical care.


Subject(s)
Anesthesiology , Cardiovascular Surgical Procedures/methods , Critical Care/methods , Anesthesiologists , Humans , Intensive Care Units
16.
J Cardiothorac Vasc Anesth ; 33(2): 511-520, 2019 02.
Article in English | MEDLINE | ID: mdl-30502310

ABSTRACT

Patients undergoing cardiovascular surgery may be exposed to heparin before surgery, during cardiopulmonary bypass (CPB), or in the immediate postoperative period. For this reason, cardiovascular surgery patients are at increased risk for heparin-induced thrombocytopenia (HIT), occurring in 1 to 3% of patients. The diagnosis of HIT can be difficult, if based solely on the development of thrombocytopenia, because cardiac surgical patients have multiple reasons to be thrombocytopenic. Several clinical scoring systems have been developed to reduce unnecessary testing and better define the pretest probability of HIT, which we will review in detail with a diagnostic algorithm. In addition, we will cover the prevention and treatment HIT.


Subject(s)
Anesthesiologists , Cardiopulmonary Bypass/adverse effects , Critical Care , Heparin/adverse effects , Thrombocytopenia/chemically induced , Anticoagulants/adverse effects , Humans , Postoperative Complications/etiology , Postoperative Complications/prevention & control , Thromboembolism/etiology , Thromboembolism/prevention & control
17.
Semin Cardiothorac Vasc Anesth ; 22(1): 18-26, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29338605

ABSTRACT

In 2017, many high-impact articles appeared in the literature. This is the third edition of an annual review of articles related to postoperative cardiac critical care that may affect the cardiac anesthesiologist. This year explores vasopressor and inotropic support, timing of renal replacement therapy, management of postoperative respiratory insufficiency, and targeted temperature therapy.


Subject(s)
Cardiotonic Agents/therapeutic use , Critical Care/methods , Heart Diseases/surgery , Hypothermia, Induced/methods , Renal Replacement Therapy/methods , Respiratory Insufficiency/therapy , Vasoconstrictor Agents/therapeutic use , Heart Diseases/complications , Humans , Postoperative Care/methods , Respiratory Insufficiency/complications , Time Factors
18.
J Cardiothorac Vasc Anesth ; 32(2): 1013-1022, 2018 04.
Article in English | MEDLINE | ID: mdl-29223724

ABSTRACT

Vasoplegic syndrome, characterized by low systemic vascular resistance and hypotension in the presence of normal or supranormal cardiac function, is a frequent complication of cardiovascular surgery. It is associated with a diffuse systemic inflammatory response and is mediated largely through cellular hyperpolarization, high levels of inducible nitric oxide, and a relative vasopressin deficiency. Cardiopulmonary bypass is a particularly strong precipitant of the vasoplegic syndrome, largely due to its association with nitric oxide production and severe vasopressin deficiency. Postoperative vasoplegic shock generally is managed with vasopressors, of which catecholamines are the traditional agents of choice. Norepinephrine is considered to be the first-line agent and may have a mortality benefit over other drugs. Recent investigations support the use of noncatecholamine vasopressors, vasopressin in particular, to restore vascular tone. Alternative agents, including methylene blue, hydroxocobalamin, corticosteroids, and angiotensin II, also are capable of restoring vascular tone and improving vasoplegia, but their effect on patient outcomes is unclear.


Subject(s)
Cardiac Surgical Procedures/adverse effects , Vascular Surgical Procedures/adverse effects , Vasoplegia/etiology , Angiotensin II/therapeutic use , Cardiopulmonary Bypass/adverse effects , Humans , Methylene Blue/therapeutic use , Risk Factors , Vasoplegia/prevention & control , Vasoplegia/therapy
20.
Trials ; 18(1): 593, 2017 Dec 13.
Article in English | MEDLINE | ID: mdl-29237510

ABSTRACT

BACKGROUND: Postoperative atrial fibrillation (POAF) is a common complication following cardiac surgery. POAF is associated with increased morbidity and hospital costs. We herein describe the protocol for a randomized controlled trial to determine if performing a posterior left pericardiotomy prevents POAF after cardiac surgery. METHODS/DESIGN: All patients submitted to cardiac surgery at our institution will be screened for inclusion into the study. The study will consist of two parallel arms with random allocation between groups to either receive a posterior left pericardiotomy or serve as a control. Masking will be done in a single-blinded fashion to the patient. Patients will be continuously monitored postoperatively for the occurrence of atrial fibrillation until discharge. At the follow-up clinic visit (15-30 days after surgery), the primary endpoint (atrial fibrillation) and other secondary endpoints, such as pleural or pericardial effusion, will be assessed. A total sample size of 350 subjects will be recruited. DISCUSSION: POAF is associated with increased morbidity, prolonged hospital stay, and increased costs after cardiac surgery. Several strategies aimed at reducing the incidence of POAF have been investigated, including beta-blockers, amiodarone, and statins, all with suboptimal results. Posterior left pericardiotomy has been associated with a reduction of POAF in previous series. However, these studies had limited sample sizes and suboptimal methodology, so that the efficacy of posterior pericardiotomy in preventing POAF remains to be definitively proven. Our randomized trial aims to determine the effect of a posterior left pericardiotomy on the incidence of POAF. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT02875405 , protocol record 1502015867. Registered on July 2016.


Subject(s)
Atrial Fibrillation/prevention & control , Cardiac Surgical Procedures/adverse effects , Pericardiectomy/methods , Atrial Fibrillation/diagnosis , Atrial Fibrillation/etiology , Clinical Protocols , Humans , New York City , Pericardiectomy/adverse effects , Prospective Studies , Research Design , Risk Factors , Single-Blind Method , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL